Sign Out
Active ingredient: Bevacizumab (humanized anti-VEGF monoclonal antibody or an antibody replicated from a human antibody that selectively binds to human vascular endothelial growth factor (VEGF)).
Versavo is supplied in 100 mg and 400 mg preservative-free, single-use vial containing 4 mL or 16 mL of Versavo. (25 mg/mL.)
Each 100 mg of Versavo contains 100 mg of Bevacizumab.
Each 400 mg of Versavo contains 400 mg of Bevacizumab.
Route of Administration: Bevacizumab is not formulated for intravitreal use. (See Precautions.)
Excipients/Inactive Ingredients: α, α-Trehalose dihydrate, Sodium dihydrogen phosphate monohydrate, di-Sodium hydrogen phosphate anhydrous, Polysorbate 20, water for injection.
Continue with Google